Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks8 of 8 passed
Key figures · 17
MetricValuePeriodScopeSource row
Revenue¥92m2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥697m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥601m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥886m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥887m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥887m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥6.3bnat 2022-09-30Cons.Assets
Total liabilities¥1.6bnat 2022-09-30Cons.Liabilities
Net assets / equity¥4.7bnat 2022-09-30Cons.Net assets
Cash and deposits¥2.8bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥1.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.1bnat 2022-03-31Cons.Cash and cash equivalents
Operating cash flow−¥669m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥708m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
EPS (basic)¥-12.662022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-7.872022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio74.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 260
ItemContextValueUnit
Major components of selling general and administrative expenses (text)CurrentYTDDurationText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Description of fact that companys business comprises single segmentCurrentYTDDuration
Original text (Japanese)当社グループは、医薬品等の研究開発及び製造販売並びにこれらの付随業務の単一セグメントであるため、記載は省略しております。
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 8 of 8 passed
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass